Literature DB >> 8406303

Repeat hepatic resection for recurrent hepatocellular carcinoma.

T Kakazu1, M Makuuchi, S Kawasaki, S Miyagawa, Y Hashikura, T Kosuge, T Takayama, J Yamamoto.   

Abstract

During the last 12 years, hepatic resection was carried out on 268 patients with a diagnosis of hepatocellular carcinoma. Of these, 78% developed tumor recurrence in the remaining liver within 5 years. The indications for repeat hepatectomy were evaluated in the same way as for the first operation. Eighteen second hepatic resections and six third hepatic resections were performed 4 to 63 months after the first hepatectomy, with no operative deaths. The cumulative survival rate of these 24 patients was 87.1% at 3 years, 87.1% at 5 years and 72.6% at 7 years after the first hepatic resection, respectively. The present results show that repeat hepatectomy can be safely indicated for recurrent tumors in patients whose liver functional status has been relatively stable since the first hepatic resection.

Entities:  

Mesh:

Year:  1993        PMID: 8406303

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  15 in total

1.  Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.

Authors:  Masami Minagawa; Masatoshi Makuuchi; Tadatoshi Takayama; Norihiro Kokudo
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

2.  Successful Anatomic Resection of Tumor-Bearing Portal Territory Delays Long-Term Stage Progression of Hepatocellular Carcinoma.

Authors:  Junichi Shindoh; Yuta Kobayashi; Ryosuke Umino; Kazutaka Kojima; Satoshi Okubo; Masaji Hashimoto
Journal:  Ann Surg Oncol       Date:  2020-07-25       Impact factor: 5.344

Review 3.  Surgical treatment of hepatocellular carcinoma: evidence-based outcomes.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

4.  Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection.

Authors:  Tsuyoshi Notake; Akira Kobayashi; Hiroji Shinkawa; Takuya Kawahara; Akira Shimizu; Takahide Yokoyama; Kiyoshi Hasegawa; Norihiro Kokudo; Yutaka Matsuyama; Masatoshi Makuuchi; Shin-Ichi Miyagawa
Journal:  Int J Clin Oncol       Date:  2017-03-16       Impact factor: 3.402

5.  Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma.

Authors:  Junichi Shindoh; Kiyoshi Hasegawa; Yosuke Inoue; Takeaki Ishizawa; Rihito Nagata; Taku Aoki; Yoshihiro Sakamoto; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  HPB (Oxford)       Date:  2012-08-26       Impact factor: 3.647

6.  Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma.

Authors:  Junichi Shindoh; Yusuke Kawamura; Yuta Kobayashi; Norio Akuta; Masahiro Kobayashi; Yoshiyuki Suzuki; Kenji Ikeda; Masaji Hashimoto
Journal:  J Gastrointest Surg       Date:  2019-06-12       Impact factor: 3.452

7.  Appropriate treatment strategy for intrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma.

Authors:  Fumitoshi Hirokawa; Michihiro Hayashi; Yoshiharu Miyamoto; Mitsuhiro Asakuma; Tetsunosuke Shimizu; Koji Komeda; Yoshihiro Inoue; Nobuhiko Tanigawa
Journal:  J Gastrointest Surg       Date:  2011-05-10       Impact factor: 3.452

Review 8.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

9.  Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization.

Authors:  Takuma Arai; Akira Kobayashi; Ayumi Ohya; Masaaki Takahashi; Takahide Yokoyama; Akira Shimizu; Hiroaki Motoyama; Norihiko Furusawa; Tsuyoshi Notake; Noriyuki Kitagawa; Hiroshi Sakai; Hiroshi Imamura; Masumi Kadoya; Shin-Ichi Miyagawa
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402

Review 10.  Surgical treatment of hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.